	Treatment for intermediate and advanced-stage hepatocellular carcinoma: does systemic therapy synergize the therapeutic efficacy of TACE? Front Immunol Li Z, Tan J, Li ZJ, Yan P, Xiang H. PMID: 42148079 [PubMed - indexed for MEDLINE]
	Yttrium-90 for the treatment of breast cancer liver metastases: a global propensity-matched study. Proc (Bayl Univ Med Cent) Miles B, Mallepally A, Oza Q, Moss J. PMID: 42148015 [PubMed - indexed for MEDLINE]
	Secretory Lysosome-Related Gene Signature Defines the Immune Microenvironment and Identifies RGS2 as a Prometastatic Factor in Hepatocellular Carcinoma. Hum Mutat Ye Z, Tang B, Zhang Y, Chen H, Li J, Ye Z, Liu X, Li J, Li D. PMID: 42147807 [PubMed - indexed for MEDLINE]
	A multi-centre, prospective trial of a methylation-based liquid biopsy for early detection of liver cancer in high-risk populations. Clin Transl Med Zhang R, Yang X, Li G, Deng Y, Liu J, Gao H, Zhao J, Cheng J, Zhao X, Yang Y, Wu Z, Gu S, Wu Y, Ma Z, Liu Y, Kang Y, Zhou G, Li H, Zhang Y, Han X, Fan J, Zhou J, Dou K, Tao K. PMID: 42145083 [PubMed - indexed for MEDLINE]
	Advances and applications of liquid biopsy approaches in hepatopancreatobiliary (HPB) cancers: a literature review. Chin Clin Oncol Hauptschein D, Uson Junior PLS, Borad MJ. PMID: 42145022 [PubMed - indexed for MEDLINE]
	Genome-wide 5-hydroxymethylcytosine in circulating cell-free DNA reflects DNA methylation dynamics for non-invasive detection of early hepatocellular carcinoma. Chin Clin Oncol Peng J, Pan X. PMID: 42145016 [PubMed - indexed for MEDLINE]
	Prognostic Value of Pathological Response After Conversion Therapy and Salvage Surgery in Unresectable Hepatocellular Carcinoma. Liver Int Chi QY, Gao XD, Wang M, Liu QY, Zeng YY, Yang LF, Liu ZJ, Wang SJ, Weng SG, Zhang ZB. PMID: 42144789 [PubMed - indexed for MEDLINE]
	Special Populations: Hepatocellular Carcinoma Risk and Liver Transplantation. Clin Liver Dis Wong RJ, Colombo M, Pinto E, Burra P. PMID: 42142901 [PubMed - indexed for MEDLINE]
	A Real-World Experience of Prognostic Factors of Survival Outcomes in a Taiwanese Population With Unresectable Hepatocellular Carcinoma Treated With First-Line Lenvatinib. Cancer Med Lee SW, Huang YJ, Tsai HJ, Lin YC, Chen CC, Lee TY, Chun-Peng Y. PMID: 42141752 [PubMed - indexed for MEDLINE]
	Spatial transcriptomic-metabolic features of tumor foci and tumor capsule in microvascular invasion with hepatocellular carcinoma: A spatial multi-omics study. PLoS Med Luo ZH, Wang N, Zhao J, Long F, Wu S, Zhong W, Chen WM, Wang B, Wang K, Yuan Y, Zhou J, Yuan C, Wang F. PMID: 42139279 [PubMed - indexed for MEDLINE]
	Delayed percentage attenuation ratio (DPAR) on multiphase CT as a quantitative predictor of early response in hepatocellular carcinoma. Narra J Supriatna Y, Bachtiar R, Makkaraeng MY, Budiman A. PMID: 42137824 [PubMed - indexed for MEDLINE]
	Hepatic and Splenic Epithelioid Angiosarcoma With Sudden Splenic Rupture as the Initial Symptom:Report of One Case and Treatment Reflection. Zhongguo Yi Xue Ke Xue Yuan Xue Bao Song Y, Liu X, Ren YL, Wang H, Wen XY, Zhang MY. PMID: 42136347 [PubMed - indexed for MEDLINE]
	HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial. Signal Transduct Target Ther Li SH, Zuo ZJ, Lu LH, Xu LZ, Wang QX, Zhao RC, Mei J, Li JB, Zheng L, Guo RP, Wei W. PMID: 42135293 [PubMed - indexed for MEDLINE]
	Pulsed Electrical Field Ablation Plus Intratumoral Immunotherapy for Hepatocellular Carcinoma. J Immunother Soule E, Vargas C, Sanchez R, Cortes E, Goodyear N, Barco R, Williams J. PMID: 42132749 [PubMed - indexed for MEDLINE]
	Prognostic significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in hepatocellular carcinoma: a retrospective multicenter study on overall and recurrence-free survival following liver resection or liver transplantation. Front Immunol Arvanitakis K, Pantzios S, Christou C, Papadopoulos V, Theocharidou E, Topalidis C, Kalopitas G, Sidiropoulos O, Chatzigeorgiou A, Mitroulis I, Koletsa T, Hytiroglou P, Katsanos G, Elefsiniotis I, Tsoulfas G, Germanidis G. PMID: 42131343 [PubMed - indexed for MEDLINE]
	Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Cell Death-related Genes and Characterization of Immune Microenvironment. Iran J Allergy Asthma Immunol Wu W, Wang Y, Zhao X, Dong K, Li M, An X, Xu Y, Wang S, Li D. PMID: 42130143 [PubMed - indexed for MEDLINE]
	Diagnostic performance of abbreviated non-contrast liver MRI for detecting synchronous colorectal liver metastases. PLoS One Charoenchue P, Rajchakom K, Amantakul A, Pojchamarnwiputh S, Thanaphakpaisarn C, Na Chiangmai W, Lertsiriladakul T. PMID: 42127098 [PubMed - indexed for MEDLINE]
	Rural-Urban Disparities in Hepatocellular Carcinoma Incidence and Mortality. JAMA Netw Open Damgacioglu H, Uygun G, Deshmukh AA, Kaseb AO, Noonan AM, Demir T. PMID: 42126878 [PubMed - indexed for MEDLINE]
	Outcomes of Combined Hepatocellular-Cholangiocarcinoma After Surgical and Nonsurgical Treatments: A 23-Year Study. Exp Clin Transplant De Godos AG, Cuadrado MB, Fuentes PP, Rodríguez Vielba PL, Díaz EA, Rodríguez FL, Tejero Pintor FJ, Sánchez DP. PMID: 42126037 [PubMed - indexed for MEDLINE]
	From Theory to Practice: Which Biomarkers Are Ready for Predicting Response in Advanced HCC? Liver Int Decraecker M, Blanc JF, Amintas S, Manaud G. PMID: 42126023 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 76129

Page 1 of 3807



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy